CME
FY2026 Q2 · Calendar Q3 2026
CME Group Inc.
CME Group delivered record Q2 2026 revenue of $1.71B (+1.4% vs consensus) and EPS of $2.99 (+2.7% surprise), with near-historical daily contract volume driven by 94% institutional participation. The stock surged 5.0% on the print with continued positive drift of +4.3% afterward. Management maintained guidance and outlined a robust product pipeline: 24/7 crypto and gold futures, Single Stock futures, Compute Futures tied to NVIDIA H100 GPU rental costs, and Treasury Link for Q4 2026. Market-data revenue grew 20% YoY. The primary overhang is ongoing CFTC litigation, with the agency's response expected in August, creating uncertainty around 24/7 and perpetual futures offerings. The bullish score moderated to 78 from 88 last quarter, reflecting regulatory uncertainty and the absence of a capex outlook. With analyst consensus at $304 versus a current price of $260, the market is weighing…
EPS surprise+2.7%
Market move+5.0%
